Want to see IN:BLISSGVS full AI Analyst Report?
Bliss Gvs Pharma Limited (BLISSGVS) Financial Statements
Bliss Gvs Pharma Limited Financial Overview
Bliss Gvs Pharma Limited's market cap is currently $68.94B. The company's EPS TTM is $12.78; its P/E ratio is 50.66; and it has a dividend yield of 0.23%. Bliss Gvs Pharma Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 9.27B | $ 8.10B | $ 7.66B | $ 7.47B | $ 7.38B |
| Gross Profit | $ 5.02B | $ 3.96B | $ 2.49B | $ 3.50B | $ 3.47B |
| Operating Income | $ 1.31B | $ 2.84B | $ 1.23B | $ 1.01B | $ 950.22M |
| EBITDA | $ 2.35B | $ 1.27B | $ 1.49B | $ 1.35B | $ 762.38M |
| Net Income | $ 1.29B | $ 842.99M | $ 754.54M | $ 708.59M | $ 150.40M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.89B | $ 1.41B | $ 1.41B | $ 684.11M | $ 1.35B |
| Total Assets | $ 14.92B | $ 13.01B | $ 12.14B | $ 11.57B | $ 11.09B |
| Total Debt | $ 217.50M | $ 881.04M | $ 998.40M | $ 1.02B | $ 1.09B |
| Net Debt | $ -133.91M | $ -1.25B | $ 767.00M | $ 769.43M | $ 874.76M |
| Total Liabilities | $ 2.61B | $ 2.09B | $ 2.11B | $ 2.39B | $ 2.62B |
| Stockholders' Equity | $ 11.93B | $ 10.50B | $ 9.67B | $ 8.84B | $ 8.19B |
| Cash Flow | |||||
| Free Cash Flow | $ 818.87M | $ 298.48M | $ 1.24B | $ -594.86M | $ 614.77M |
| Operating Cash Flow | $ 1.39B | $ 1.06B | $ 1.52B | $ 343.13M | $ 1.35B |
| Investing Cash Flow | $ -382.80M | $ -754.41M | $ -1.33B | $ -77.51M | $ -929.75M |
| Financing Cash Flow | $ -892.11M | $ -303.45M | $ -208.93M | $ -249.38M | $ -237.30M |
Currency in INR